Correlation Between Tanvex BioPharma and Cameo Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tanvex BioPharma and Cameo Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tanvex BioPharma and Cameo Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tanvex BioPharma and Cameo Communications, you can compare the effects of market volatilities on Tanvex BioPharma and Cameo Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tanvex BioPharma with a short position of Cameo Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tanvex BioPharma and Cameo Communications.

Diversification Opportunities for Tanvex BioPharma and Cameo Communications

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tanvex and Cameo is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Tanvex BioPharma and Cameo Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cameo Communications and Tanvex BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tanvex BioPharma are associated (or correlated) with Cameo Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cameo Communications has no effect on the direction of Tanvex BioPharma i.e., Tanvex BioPharma and Cameo Communications go up and down completely randomly.

Pair Corralation between Tanvex BioPharma and Cameo Communications

Assuming the 90 days trading horizon Tanvex BioPharma is expected to generate 1.36 times more return on investment than Cameo Communications. However, Tanvex BioPharma is 1.36 times more volatile than Cameo Communications. It trades about 0.23 of its potential returns per unit of risk. Cameo Communications is currently generating about -0.09 per unit of risk. If you would invest  6,130  in Tanvex BioPharma on August 31, 2024 and sell it today you would earn a total of  1,100  from holding Tanvex BioPharma or generate 17.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tanvex BioPharma  vs.  Cameo Communications

 Performance 
       Timeline  
Tanvex BioPharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tanvex BioPharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Cameo Communications 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cameo Communications are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cameo Communications showed solid returns over the last few months and may actually be approaching a breakup point.

Tanvex BioPharma and Cameo Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tanvex BioPharma and Cameo Communications

The main advantage of trading using opposite Tanvex BioPharma and Cameo Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tanvex BioPharma position performs unexpectedly, Cameo Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cameo Communications will offset losses from the drop in Cameo Communications' long position.
The idea behind Tanvex BioPharma and Cameo Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device